CAR T cells co-expressing soluble or membrane-bound IL-15 provide enhanced tumor cytotoxicity, increased expansion, decreased exhaustion and a higher frequency of TSCM and TCM cells compared with parental CAR T cells lacking IL-15 enhancement (18, 59, 60). The gene discussed is IL15; the disease is neoplasm.